Retatrutide (LY3437943): identifiers, form, and laboratory handling

Retatrutide is the international nonproprietary name for the research code LY3437943. The community abbreviation RETA appears in the same literature indexes. This article is for matching a vial and a certificate to those identifiers. It is not a protocol, a dosing guide, or a product claim.

Edinburgh Peptides lists lyophilised research vials in 10, 20, 30 and 50 mg fills. Confirm the name, code, and CAS on the issued Certificate of Analysis before the material enters a protocol. Research & Development purposes only — not for human or animal consumption.

Identifiers you should see in the same place

Papers, supplier files, and certificates do not always print the same string first. Treat these as aliases for one substance, then check that your batch paperwork uses the same set.

What the literature class label is — and is not

Methods papers often describe this sequence as a GIP, GLP-1 and glucagon receptor agonist. That is how chemical databases and citations index the molecule. It is not a use instruction, a clinical indication, or a reason to treat the vial as a medicine.

This house supplies the lyophilised material for qualified laboratory research only. Do not read receptor-class language as a reconstitution recipe or a personal-use prompt.

Form on the listing

The catalogue vials are lyophilised powder in a sealed research vial. Appearance should match what the COA records for that batch (typically a white to off-white cake or powder). A wetted, discoloured, or unsealed vial is a handling problem, not a different grade.

Listed fills are 10 mg, 20 mg, 30 mg and 50 mg. Those numbers are the labelled mass of the fill, not a recommended experimental concentration. How you dissolve and aliquot is defined by your validated protocol.

Matching the vial to the COA

Before the vial is opened, walk the certificate against the physical pack.

• Product name and research code match the label.
• CAS on the COA is 2381089-83-2, or the certificate states why it uses another identifier.
• Batch / lot on the COA is the same string as on the vial.
• Fill size on the listing (10, 20, 30 or 50 mg) is the size you ordered.
• Storage statement on the COA is compatible with how you will hold the unopened vial.

Laboratory handling in brief

Lyophilised peptides are sensitive to heat, moisture and repeated freeze–thaw. Hold unopened vials at the temperature stated on the listing and the COA, keep them dry, and bring the vial to room temperature before opening so condensate does not wet the cake.

Once reconstituted, split the solution into single-use aliquots sized to your assay block rather than warming the parent vial for every run. Record solvent, concentration, date, and batch number on each aliquot. That is lot control, not a dosing schedule.

A 10 mg vial is typically a small working stock. A 50 mg vial is a bulk fill so many aliquots can share one certificate. Choose the pack for how you will split the lot — not because the larger vial is a different substance.

What this article does not cover

• Human or animal use, reconstitution volumes framed as injections, or outcome claims.
• A recommended experimental concentration or assay design.
• Substitution of HPLC purity for net peptide content when you calculate a molarity.